Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for Chronic Neuropathic Low Back Pain
NCT01298466Phase 4Withdrawn
- Sponsor
- Viatris
- Start
- Feb 2012
- Primary completion
- Feb 2013
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of pregabalin in neuropathic low back pain (NLBP), sponsored by Viatris. Planned start Feb 2012; status: withdrawn.
02
Drugs
pregabalin
03
Conditions
neuropathic low back pain (NLBP)
Beyond the preview
Go deeper on NCT01298466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01298466.